Business Description
Jiangsu Hengrui Pharmaceuticals Co Ltd
NAICS : 325412
SIC : 2834
ISIN : CNE0000014W7
Description
Financial Strength
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 261.54 | |||||
Equity-to-Asset | 0.91 | |||||
Debt-to-EBITDA | 0.02 | |||||
Interest Coverage | 101.7 | |||||
Piotroski F-Score | 7/9 | |||||
Altman Z-Score | 46.44 | |||||
Beneish M-Score | -2.97 | |||||
WACC vs ROIC |
Growth Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -6 | |||||
3-Year EBITDA Growth Rate | -9.6 | |||||
3-Year EPS without NRI Growth Rate | -11.4 | |||||
3-Year FCF Growth Rate | 29.4 | |||||
3-Year Book Growth Rate | 10 | |||||
Future 3-5Y EPS without NRI Growth Rate | 22.34 | |||||
Future 3-5Y Total Revenue Growth Rate | 13.66 |
Momentum Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 38.29 | |||||
9-Day RSI | 36.72 | |||||
14-Day RSI | 40.09 | |||||
6-1 Month Momentum % | 19.81 | |||||
12-1 Month Momentum % | 9.68 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 9 | |||||
Quick Ratio | 8.34 | |||||
Cash Ratio | 5.98 | |||||
Days Inventory | 233.73 | |||||
Days Sales Outstanding | 77.15 | |||||
Days Payable | 151.7 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 0.44 | |||||
Dividend Payout Ratio | 0.23 | |||||
Forward Dividend Yield % | 0.44 | |||||
5-Year Yield-on-Cost % | 0.42 | |||||
3-Year Average Share Buyback Ratio | 0.1 | |||||
Shareholder Yield % | 0.53 |
Profitability Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 85.76 | |||||
Operating Margin % | 22.77 | |||||
Net Margin % | 20.96 | |||||
FCF Margin % | 24.17 | |||||
ROE % | 13.07 | |||||
ROA % | 11.87 | |||||
ROIC % | 24.6 | |||||
ROC (Joel Greenblatt) % | 46.55 | |||||
ROCE % | 14.01 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 53.72 | |||||
Forward PE Ratio | 45.38 | |||||
PE Ratio without NRI | 52.86 | |||||
Shiller PE Ratio | 66.68 | |||||
Price-to-Owner-Earnings | 71.31 | |||||
PS Ratio | 11.12 | |||||
PB Ratio | 6.74 | |||||
Price-to-Tangible-Book | 7.55 | |||||
Price-to-Free-Cash-Flow | 46.09 | |||||
Price-to-Operating-Cash-Flow | 36.58 | |||||
EV-to-EBIT | 45.35 | |||||
EV-to-Forward-EBIT | 56.55 | |||||
EV-to-EBITDA | 45.35 | |||||
EV-to-Forward-EBITDA | 50.01 | |||||
EV-to-Revenue | 10.37 | |||||
EV-to-Forward-Revenue | 10.75 | |||||
EV-to-FCF | 42.92 | |||||
Price-to-Projected-FCF | 4.64 | |||||
Price-to-Median-PS-Value | 0.92 | |||||
Price-to-Graham-Number | 4.23 | |||||
Price-to-Net-Current-Asset-Value | 9.91 | |||||
Price-to-Net-Cash | 16.2 | |||||
Earnings Yield (Greenblatt) % | 2.21 | |||||
FCF Yield % | 2.15 | |||||
Forward Rate of Return (Yacktman) % | -7.03 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Jiangsu Hengrui Pharmaceuticals Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil ¥) | 25,995.457 | ||
EPS (TTM) (Â¥) | 0.86 | ||
Beta | 1.25 | ||
Volatility % | 38.89 | ||
14-Day RSI | 40.09 | ||
14-Day ATR (Â¥) | 1.126426 | ||
20-Day SMA (Â¥) | 48.138 | ||
12-1 Month Momentum % | 9.68 | ||
52-Week Range (Â¥) | 35.51 - 57.53 | ||
Shares Outstanding (Mil) | 6,379 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 7 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Jiangsu Hengrui Pharmaceuticals Co Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Jiangsu Hengrui Pharmaceuticals Co Ltd Stock Events
Event | Date | Price(Â¥) | ||
---|---|---|---|---|
No Event Data |
Jiangsu Hengrui Pharmaceuticals Co Ltd Frequently Asked Questions
What is Jiangsu Hengrui Pharmaceuticals Co Ltd(SHSE:600276)'s stock price today?
When is next earnings date of Jiangsu Hengrui Pharmaceuticals Co Ltd(SHSE:600276)?
Does Jiangsu Hengrui Pharmaceuticals Co Ltd(SHSE:600276) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |